FdaApplication
ANDA 203071
Identifiers
- fda_app_no: ANDA203071
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2012-09-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IRBESARTAN | IRBESARTAN | 150MG | TABLET;ORAL |
| IRBESARTAN | IRBESARTAN | 300MG | TABLET;ORAL |
| IRBESARTAN | IRBESARTAN | 75MG | TABLET;ORAL |
3 products